Chemical Structure : SAR 125844
CAS No.: 1116743-46-4
Catalog No.: PC-60463Not For Human Use, Lab Use Only.
SAR 125844 is a potent, highly selective, ATP-competitive MET receptor tyrosine kinase inhibitor with IC50 of 4.2 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
1 mg (Free Sample) | $18 | In stock | |
5 mg | $78 | In stock | |
10 mg | $128 | In stock | |
25 mg | $218 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SAR 125844 is a potent, highly selective, ATP-competitive MET receptor tyrosine kinase inhibitor with IC50 of 4.2 nM.
SAR 125844 also inhibits H1094Y, Y1235D, M1250T, L1195V, and D1228H mutants with IC50 of 0.22, 1.7, 6.5, 65, and 81 nM, respectively.
SAR 125844 displays >100-fold selectivity over RON, and good selectivity in a panel of 275 human kinases.
SAR 125844 inhibits phosphorylation of wild-type MET, M1250T, Y1235D, and L1195V MET mutants with IC50 of 8.8, 30, 179, and 591 nM, respectively.
selectively inhibits proliferation in cells with MET gene amplification, promotes apoptosis and inhibits HGF-mediated tumor cell migration; displays potent antitumor activity in vivo models.
M.Wt | 550.631 | |
Formula | C25H23FN8O2S2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea |
1. Egile C, et al. Mol Cancer Ther. 2015 Feb;14(2):384-94.
2. Ugolini A, et al. J Med Chem. 2016 Aug 11;59(15):7066-74.
3. Shitara K, et al. Oncotarget. 2017 Jun 16;8(45):79546-79555.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright